Home › Funds › Harding Loevner International Small Companies Portfolio
Fund family: HARDING LOEVNER FUNDS INC · Filed by HARDING LOEVNER FUNDS INC (CIK 1018170) · SEC series S000016295
Share classes and tickers: HLMRX (C000045116), HLMSX (C000045117), HLRZX (C000240396)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 1,068 with, 9 against, 19 abstentions (not counted as with management); 11 items carried no recommendation. Shareholder proposals: 7 FOR, 9 AGAINST, 0 abstained, by the filing’s own vote-source field.
Each ballot item this fund voted is set against the votes of the other HARDING LOEVNER FUNDS INC funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most HARDING LOEVNER FUNDS INC funds on all 13 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 362 | 1 |
| Corporate Governance | 188 | 5 |
| Capital Structure | 185 | 1 |
| Other | 124 | 0 |
| Audit-related | 88 | 0 |
| Compensation | 81 | 1 |
| Say-on-Pay | 43 | 0 |
| Extraordinary Transactions | 23 | 0 |
| Other Social Issues | 12 | 0 |
| Shareholder Rights and Defenses | 1 | 1 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 24, 2026 | ROHTO PHARMACEUTICAL CO.,LTD. | Shareholder Proposal: Remove a Director Yamada, Kunio Shareholder proposal | Against | For |
| June 24, 2026 | ROHTO PHARMACEUTICAL CO.,LTD. | Shareholder Proposal: Amend Articles of Incorporation (the establishment of a Strategic Review Committee) Shareholder proposal | Against | For |
| June 10, 2026 | RUBIS SCA | PLEASE NOTE THAT THIS RESOLUTION IS A SHAREHOLDER PROPOSAL: APPOINTMENT OF YANN DEVER AS A MEMBER OF THE SUPERVISORY BOARD FOR A TERM OF THREE YEARS Shareholder proposal | Against | For |
1,107 ballot items at 97 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Harding Loevner International Small Companies Portfolio (HLMRX) voted at 97 shareholder meetings of 73 companies, on 1,107 ballot items in all. Where management made a recommendation, the fund followed it on 97.4% of the items and voted against it 9 times. Its most frequent area of disagreement was corporate governance (5 of its votes against management). It voted on 16 shareholder proposals. It voted the same way as most HARDING LOEVNER FUNDS INC funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.